- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05262972
Percutaneous Needle Electrolysis on Metatarsalgia
APPLICATION OF ULTRASOUND-GUIDED PERCUTANEOUS ELECTROLYSIS IN THE PAIN OF THE SECOND METATARSOPHALANGEAL JOINT IN ADULT WOMEN
Percutaneous electrolysis is a minimally invasive method that involves the application of a galvanic current through an acupuncture needle. The needle is placed directly into the soft tissue structures, essential with ultrasound guidance. This technique involves the combination of mechanical stimulation produced by the needle and electrical/biochemical stimulation provided by the electrical current.
Endogenous pain modulation shows clinical relevance of this technique and plays an important role in the experience of pain.
Plantar plate injury is a pathology that frequently occurs in the forefoot, especially in middle-aged women, causing metatarsalgia that is sometimes very intense. In most cases it is secondary to a mechanical imbalance of the forefoot, related to an insufficiency of the first radius. For this reason, the researchers hypothesize that the application of ultrasound-guided percutaneous electrolysis on the plantar plate, combined with the conservative treatment consisting of the development of a personalized plantar orthosis, can cause positive effects in the patient's clinic as well as improve their quality of life.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Blanca De la Cruz Torres, Dr
- Phone Number: 666676870
- Email: bcruz@us.es
Study Locations
-
-
-
Seville, Spain
- Recruiting
- Blanca de la Cruz
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult female patients (40-65 years old)
- Having pain in the 2nd MTP joint of the foot due to pathology of the plantar plate, diagnosed by a specialized professional.
Exclusion Criteria:
- to have suffered an injury to their musculoskeletal system in the last 6 months.
- to have the present neuritic pathology,
- to have complete rupture of the plantar plate, 2nd finger supraadductus, flexor digitorum longus tenosynovitis,
- to have problems in the lumbar spine,
- to have undergone surgery in the lumbar spine or lower limbs.
- to use a plantar orthosis.
- to have the presence of associated pathologies in the foot,
- to be under the influence of any medication at the time of the study, fear of needles
- to be pregnant
- to be epileptic.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group I
The subject will obtain a conservative treatment for this type of pathology consisting of the development of a personalized plantar orthosis
|
Personalized plantar orthosis
|
Experimental: Group II
The subjects belonging to this group, in addition to providing their corresponding personalized plantar orthosis, will receive a complementary treatment consisting of the application of ultrasound-guided percutaneous electrolysis
|
Personalized plantar orthosis + percutaneous electrolysis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life
Time Frame: 1 month
|
Foot Health Status Questionnaire
|
1 month
|
Subjetive level of pain
Time Frame: 1 month
|
Intensity of subjective pain in the injured structure (0, no pain; 10, worse pain)
|
1 month
|
level of pain at palpation
Time Frame: 1 month
|
Intensity of pain on palpation in the injured structure (0, no pain; 10, worse pain)
|
1 month
|
Distribution of plantar pressures
Time Frame: 1 month
|
Podiatric platform (pressure percentage 0-100%)
|
1 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PNE and metatarsalgia
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metatarsalgia
-
University of PadovaUnknownMetatarsalgia BilateralItaly
-
Copenhagen University Hospital, HvidovreCompleted
-
Galderma R&DCompleted
-
Manuel Cuervas-MonsUnknown
-
Universidad de ExtremaduraCompletedPain | Foot Diseases | MetatarsalgiaSpain
-
Chinese University of Hong KongPamela Youde Nethersole Eastern HospitalActive, not recruitingMetatarsalgiaHong Kong
-
Taipei Veterans General Hospital, TaiwanCompleted
-
Universidade Federal do Rio Grande do NorteCompletedMetatarsalgia | Heel Pain SyndromeBrazil
-
Schoenhaus, Jodi, DPMUnknownMetatarsalgia | Fat Pad Syndrome | Corns | Hyperkeratotic CallusUnited States
Clinical Trials on Conservatory treatment
-
University of SevilleCompleted
-
PfizerCompleted
-
PfizerCompleted
-
Chiesi Farmaceutici S.p.A.Completed
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States
-
PfizerCompleted
-
JW PharmaceuticalCompletedHealthyKorea, Republic of
-
AstraZenecaParexelCompleted
-
Assistance Publique - Hôpitaux de ParisRecruitingIntra-articular Fracture of the Mandibular CondyleFrance
-
New Mexico VA Healthcare SystemCompletedPost Traumatic Stress DisorderUnited States